Log in
Enquire now
Horizon Discovery

Horizon Discovery

Horizon Discovery is a company that offers gene editing, CRO, and diagnostics services

OverviewStructured DataIssuesContributors

Contents

horizondiscovery.com
Is a
Company
Company
Organization
Organization

Company attributes

Industry
RNA
RNA
Drug discovery
Drug discovery
Biopharmaceutical
Biopharmaceutical
Diagnosis
Diagnosis
DNA sequencing
DNA sequencing
‌
Equipment
Technology
Technology
...
Location
‌
Cambridge, Missouri
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire
B2X
B2B
B2B
CEO
‌
Terry Pizzie
Founder
Darrin M Disley
Darrin M Disley
AngelList URL
angel.co/horizon-discovery
Pitchbook URL
pitchbook.com/profiles.../53653-24
Legal Name
Horizon Discovery, Inc.
Legal classification
Incorporation (business)
Incorporation (business)
Date Incorporated
February 14, 2005
Number of Employees (Ranges)
201 – 500
Full Address
8100 Cambridge Research Park Waterbeach Cambridge CB25 9TL England, United Kingdom
Investors
‌
MVM Life Science Partners
MVM
MVM
Roche Venture Fund
Roche Venture Fund
University of Cambridge Enterprise
University of Cambridge Enterprise
Wren Capital
Wren Capital
Jonathan Milner
Jonathan Milner
DFJ
DFJ
ValueAct Capital
ValueAct Capital
...
Founded Date
2005
0
Total Funding Amount (USD)
30,888,863
Latest Funding Round Date
September 7, 2018
Competitors
Bit.bio
Bit.bio
Exchange
Alternative Investment Market
Alternative Investment Market
Acquisition Transaction
‌
Acquisition of Horizon Discovery by PerkinElmer
Latest Funding Type
Series C
Series C
Patents Assigned (Count)
2
Wellfound ID
horizon-discovery
Technologies Used
CRISPR
CRISPR
CRISPR interference
CRISPR interference
CRISPR-Cas9
CRISPR-Cas9
Country
United Kingdom
United Kingdom
Headquarters
Cambridge, Cambridgeshire
Cambridge, Cambridgeshire

Other attributes

Acquirer
PerkinElmer
PerkinElmer
Blog
horizondiscovery.com/news/
Company Operating Status
Active
Wikidata ID
Q16984856

Gene editing refers to the process of changing regions of cellular DNA. The most common gene editing techniques involve inactivating a gene’s function (knockout), introducing or correcting a SNP mutation, or adding a reporter tag to an endogenous gene (knock-in). These changes are permanent and heritable, resulting in a newly engineered cell line.

With our Edit-R™ CRISPR-Cas9 reagents, researchers can make targeted, specific edits to any gene in practically any cell type. Additionally, Horizon offers a wide selection of pre-made edited cell lines and expert genome engineering services.

Edit-R™ gene editing reagents

Guaranteed to edit your target gene

Algorithm designed CRISPR guide RNA to maximize functional protein knockout and minimize off-target effects.

Also find numerous Cas9 nuclease options, positive and non-targeting controls, and donor templates for HDR-mediated knock-in applications.

Engineered cell models

Ready-to-go or tailored for individual needs

Find 1000's of validated knockout models, point mutations in cancer-relevant cell models, and "CRISPR-ready" stable Cas9 or dCas9-VPR expressing cell lines.

Or use our online tool to design your own cell line and get an instant quote and timeline for your next cell line engineering project.

Horizon Discovery is a developer of applications for gene editing and gene modulation for the life sciences market to support scientists in research and therapy.

Timeline

No Timeline data yet.

Funding Rounds

Products

Acquisitions

SBIR/STTR Awards

Patents

Further Resources

Title
Author
Link
Type
Date
No Further Resources data yet.

References

Find more companies like Horizon Discovery

Use the Golden Query Tool to find similar companies in the same industry, location, or by any other field in the Knowledge Graph.
Open Query Tool
Access by API
Golden Query Tool
Golden logo

Company

  • Home
  • Press & Media
  • Blog
  • Careers
  • WE'RE HIRING

Products

  • Knowledge Graph
  • Query Tool
  • Data Requests
  • Knowledge Storage
  • API
  • Pricing
  • Enterprise
  • ChatGPT Plugin

Legal

  • Terms of Service
  • Enterprise Terms of Service
  • Privacy Policy

Help

  • Help center
  • API Documentation
  • Contact Us
By using this site, you agree to our Terms of Service.